Wangyi, Associate Director of Administration Committee of North New Zone (CNNZ) met Steven Hardacre, Managing Director of Merck & Co., Inc. in West China, and other members of the delegation in Xingguang Building on March 2. The delegation aimed to know the development of medical service outsourcing associated industries in CNNZ and preferential policies provided for enterprise-in-residence by government. During the meeting, the two parties specifically shared views on relevant policies for Merck & Co.,Inc. to open an office, and put forward the strategic orientation of futher cooperation. More discussion on how to push forward the Merck & Co Inc-Chongqing Project followed later. At last, the delegation visited industrial buildings.

    Merck & Co., Inc., with headquarters in New Jersey, US, is the world's leader of pharmaceutical enterprises. It is a scientific-research-oriented transnational pharmaceutical enterprises focusing on the research, development and sale of innovative pharmaceutical products. In 2009, Merck & Co., Inc. had employed 55.2 thousand people worldwide, with 28 thousand in America, and its operations covered 200 countries/regions. It had 10 research centers and 33 manufacturers in the world and 17 distribution centers in 25 countries. The worldwide sales of Merck & Co., Inc. In 2005 reached 2.2 billion dollars.

    Du Yaowu, director of Info-service Outsourcing Office of CNNZ, and the Project Supervisor presented the reception.